Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-28T21:03:01.910Z Has data issue: false hasContentIssue false

15 - Platelet phospholipases A2

from PART I - PHYSIOLOGY

Published online by Cambridge University Press:  10 May 2010

Michael H. Gelb
Affiliation:
Departments of Chemistry and Biochemistry, University of Washington, Seattle, USA
Carine M. Mounier
Affiliation:
Département de Biologie, Université de Cergy-Pontoise, France
Ying Hefner
Affiliation:
Departments of Chemistry and Biochemistry, University of Washington, Seattle, USA
Steve P. Watson
Affiliation:
Department of Pharmacology, University of Oxford, UK
Paolo Gresele
Affiliation:
Università degli Studi di Perugia, Italy
Clive P. Page
Affiliation:
Sackler Institute of Pulmonary Pharmacology and Therapeutics, Guy's, King's and St Thomas' School of Biomedical Sciences, London
Valentin Fuster
Affiliation:
Mount Sinai Medical Center and School of Medicine, New York
Jos Vermylen
Affiliation:
Universiteitsbibliotheek-K.U., Leuven
Get access

Summary

Introduction

The major physiological role of platelets is in the cessation of bleeding following damage to the vasculature. Ordinarily, platelets circulate within intact blood vessels in a quiescent state, but undergo extremely rapid and powerful activation upon exposure to the subendothelial matrix leading to formation of a platelet aggregate or vascular plug. This rapid response is achieved by the stimulatory action of a range of diverse agonists including extracellular matrix proteins, e.g. collagen, and products of the coagulation cascade, e.g. thrombin. Activation is reinforced through release of agonists from platelet granules, notably ADP, and liberation of thromboxane A2 (TxA2), the major product of the metabolism of arachidonic acid (AA) in the platelet. The positive feedback action of ADP and TxA2 is of direct clinical relevance. The Antiplatelet Trialists' Collaboration published a summary of 20 randomized trials in 1988, concluding that antiplatelet therapy significantly reduces (by ∼ 25%) the risk of cardiovascular death, non-fatal myocardial infarction and nonfatal stroke in patients with unstable angina or a past history of heart attack, transient ischemic attack, or stroke. A follow-up report by the same group, confirmed the efficacy of platelet inhibition in a broader spectrum of pathological conditions. More recently, the CAPRIE study has shown that the ADP receptor antagonist, clopidogrel, and aspirin have a similar therapeutic benefit in individuals with a history of thrombotic disease. Aspirin, however, remains the drug of choice in the majority of cases primarily for reasons of cost.

Type
Chapter
Information
Platelets in Thrombotic and Non-Thrombotic Disorders
Pathophysiology, Pharmacology and Therapeutics
, pp. 221 - 237
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×